Palvella Therapeutics, Inc. · NASDAQ:PVLA

James N. Topper reported a 5.10% stake in Palvella Therapeutics, Inc. (Schedule 13G)

Event Dec 13, 2024 · Filed Jan 8, 2025

James N. Topper reported a 5.10% stake in Palvella Therapeutics, Inc., 575,892 shares, as a passive investor on Dec 13, 2024. Filed Jan 8, 2025 (Schedule 13G).

Stake: 5.10%
Shares: 575,892
Intent: Passive
What changed: Crossed above 5%
Filed together: 17 holders

The filing in full

Holder	Stake	Shares
Frazier Life Sciences Public Fund, L.P.	3.90%	440,575
FHMLSP, L.P.	3.90%	440,575
FHMLSP, L.L.C.	3.90%	440,575
Frazier Life Sciences Public Overage Fund, L.P.	1.20%	129,905
FHMLSP Overage, L.P.	1.20%	129,905
FHMLSP Overage, L.L.C.	1.20%	129,905
Frazier Life Sciences X, L.P.	0%	2,648
FHMLS X, L.P.	0%	2,648
FHMLS X, L.L.C.	0%	2,648
Frazier Life Sciences XI, L.P.	0%	2,764
FHMLS XI, L.P.	0%	2,764
FHMLS XI, L.L.C.	0%	2,764
James N. Topper	5.10%	575,892
Patrick J. Heron	5.10%	575,892
Albert Cha	5.10%	570,480
James Brush	5.10%	570,480
Daniel Estes	0%	2,764

Source

View original at SEC

Related